Hamilton Lane Incorporated is an investment firm specializing in direct and fund of fund investments. It provides following services: separate accounts (customized to each individual client and structured as single client vehicles); specialized strategies (fund-of-funds, secondaries, co-investments, taft-hartley, distribution management); advisory relationships (including due diligence, strategic portfolio planning, monitoring and reporting services); and reporting and analytics solutions. For direct investments, the firm invests in early, mid and late venture, mature companies, growth equity, emerging growth, distressed debt, later stage, turnarounds, bridge financing, mezzanine financing, and buyouts in middle market companies. For fund of fund investments, it invests in mezzanine, venture capital, private equity, turnaround, secondary investments, real estate, and special situation funds. The firm invests in real estate investments. It also invest in technology, healthcare, education, natural resources, energy and essential consumer goods sectors, cleantech, and environment, community development, and financial empowerment. It invests in private equity markets in North America, Latin America, United States, Western Europe, Middle East, Africa, United Kingdom, Asia, Japan, and Australia. The firm prefer to invest $1 million to $100 million in companies. It prefers to have majority stake in companies. Hamilton Lane Incorporated was founded in 1991 and is based in Conshohocken, Pennsylvania with additional offices across Europe, North America, and Asia.
IPO Year: 2017
Exchange: NASDAQ
Website: hamiltonlane.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/21/2025 | $186.00 | Perform → Outperform | Oppenheimer |
| 1/6/2025 | $139.00 | Neutral → Sell | Goldman |
| 9/12/2024 | $156.00 | Equal Weight | Wells Fargo |
| 4/11/2024 | $115.00 | Overweight → Neutral | JP Morgan |
| 1/11/2024 | Outperform → Perform | Oppenheimer | |
| 5/26/2023 | $87.00 | Perform → Outperform | Oppenheimer |
| 3/15/2023 | $85.00 | Neutral → Overweight | JP Morgan |
| 8/9/2022 | $72.00 → $75.00 | Buy → Neutral | UBS |
| 1/21/2022 | $120.00 → $111.00 | Equal-Weight | Morgan Stanley |
| 12/16/2021 | $109.00 | Equal-Weight | Wells Fargo |
3 - Hamilton Lane INC (0001433642) (Issuer)
4 - Hamilton Lane INC (0001433642) (Issuer)
4 - Hamilton Lane INC (0001433642) (Issuer)
4 - Hamilton Lane INC (0001433642) (Issuer)
4 - Hamilton Lane INC (0001433642) (Issuer)
4 - Hamilton Lane INC (0001433642) (Issuer)
4 - Hamilton Lane INC (0001433642) (Issuer)
4 - Hamilton Lane INC (0001433642) (Issuer)
4 - Hamilton Lane INC (0001433642) (Issuer)
4 - Hamilton Lane INC (0001433642) (Issuer)
CONSHOHOCKEN, Pa., May 8, 2025 /PRNewswire/ -- Hamilton Lane Incorporated (NASDAQ:HLNE) is scheduled to release financial results for the fourth fiscal quarter and full fiscal year ended March 31, 2025 before the market opens on Thursday, May 29, 2025. A copy of the earnings release and full detailed presentation will be available on the Hamilton Lane Shareholders website at https://shareholders.hamiltonlane.com/. Hamilton Lane will host a conference call via webcast at 11:00 a.m. ET on May 29 to discuss the results for the fourth fiscal quarter and full fiscal year. For access to the live event via the webcast, visit Hamilton Lane's Shareholder's website by clicking here (https://sharehold
Fund offers access to private venture and growth investments including disruptive technologies and innovative businesses CONSHOHOCKEN, Pa., May 6, 2025 /PRNewswire/ -- Leading private markets investment firm Hamilton Lane (NASDAQ:HLNE) today announced the launch of the Hamilton Lane Venture Capital and Growth Fund ("HLVCG" or "the Fund"), a continuously offered evergreen investment vehicle registered under the Investment Act of 1940 ("40 Act"), available to accredited U.S. investor clients, including high-net-worth investors and their advisors2, as well as institutional investors. HLVCG offers investors in the U.S. access to the firm's global venture capital investment platform with what th
Grenova, Inc., a Virginia-based innovator in sustainable laboratory technologies, today announced two significant milestones for the company: the appointment of Ted Hull to Grenova's board, and the successful completion of a new round of growth equity capital. These developments support Grenova's strategic vision to drive innovation, expand automation capabilities, and deliver transformative solutions to laboratories worldwide. Ted Hull brings over 30 years of experience in the life sciences industry, including as a clinical lab CEO for the last 20+ years. In his role at Grenova, Mr. Hull is set to provide strategic leadership and to play a pivotal role in shaping the company's future. "I
RED BANK, N.J., April 17, 2025 /PRNewswire/ -- PAX Health, a leading behavioral healthcare company backed by HCAP Partners and funds managed by Hamilton Lane (NASDAQ:HLNE), today announced its acquisition of Richardson Psychiatric Associates, a comprehensive outpatient psychiatric practice serving adults, adolescents, children, and families. This strategic acquisition enhances PAX Health's portfolio of mental health services and expands its geographic footprint in Western Pennsylvania, strengthening the company's ability to deliver high-quality psychiatric care across diverse
CONSHOHOCKEN, Pa., March 25, 2025 /PRNewswire/ -- Hamilton Lane (NASDAQ:HLNE), a leading global private markets investment management firm, announced an investment in a portfolio of four multifamily assets in lower Manhattan. Funds managed by Hamilton Lane have acquired an 85% interest in the assets of a family office seller. The portfolio comprises 126 multifamily units and 11,050 square feet of prime ground-floor retail space in the highly desired New York City neighborhoods of the West Village and SoHo. Dalan Real Estate is a vertically integrated real estate firm specializing in New York City multifamily properties. Dalan will retain its 15% interest in the portfolio and will continue
Hamilton Lane Private Infrastructure Fund ("HLPIF") allows retail investors access to infrastructure assets previously accessible only to Hamilton Lane's institutional clientsIntention to offer investors access to HLPIF in a first-of-its-kind tokenized format through Republic's digital platform CONSHOHOCKEN, Pa. and NEW YORK, March 19, 2025 /PRNewswire/ -- Hamilton Lane (NASDAQ:HLNE), one of the world's largest private markets investment firms, today announced the launch of HLPIF on the global investment platform Republic*. HLPIF is the first private infrastructure offering available to retail (non-accredited) investors in the U.S. with a minimum as low as $500 via the Republic platform, wh
Research findings note some areas of concern in private markets in the short-term, with positive tailwinds across long-term fundamentals Report also highlights strong runway for growth within evergreenCONSHOHOCKEN, Pa., March 12, 2025 /PRNewswire/ -- Hamilton Lane (NASDAQ:HLNE), a leading global private markets investment management firm, published its 2025 Market Overview today. This year's report offers a nuanced picture of the global private markets landscape, backed by historical data around outperformance, downside risk and diversification benefits, as well as a burgeoning evergreen landscape, demonstrating its compelling case for a growing number of investors.
Fund leverages firm's 24+ years of experience in the secondary market and extensive scale to capitalize on what the firm believes to be attractive long-term growth trends CONSHOHOCKEN, Pa., March 3, 2025 /PRNewswire/ -- Leading private markets investment management firm Hamilton Lane (NASDAQ:HLNE) today announced the launch of the Hamilton Lane Private Secondary Fund ("HLPSF" or "the Fund"), a continuously offered evergreen investment vehicle registered under the Investment Company Act of 1940 ("40 Act"), available to U.S. accredited investor clients, including sufficiently qualified high-net-worth investors and their wealth advisors. HLPSF offers private wealth and institutional investo
-- Acquisition Propels Cosette Into One Of The Leading Companies In Women's Health and Dermatology in the U.S. -- -- Highly Complementary Business Strengthens Cosette's Portfolio, Commercial and Manufacturing Footprint and Expands Geographic Reach -- -- Utilizing Mayne Pharma's Impressive Commercial and Sales Track Record to Drive Further Growth and Enhanced Patient Access -- Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total consideration of approximately USD
73 Strings is revolutionizing private capital markets through AI-powered data extraction, portfolio monitoring, and valuation solutions Funds will be used to further accelerate product development and innovation 73 Strings, the financial intelligence platform using AI to revolutionize data extraction, monitoring, and valuation for the $17.6 Trillion AUM Alternative Asset Management space, has successfully closed a $55m Series B. The round was led by Growth Equity at Goldman Sachs Alternatives, with continued investment from Blackstone Innovations Investments and participation from Golub Capital, Hamilton Lane (NASDAQ:HLNE) and Broadhaven Ventures, solidifying 73 Strings' reputation as th
CONSHOHOCKEN, Pa., May 8, 2025 /PRNewswire/ -- Hamilton Lane Incorporated (NASDAQ:HLNE) is scheduled to release financial results for the fourth fiscal quarter and full fiscal year ended March 31, 2025 before the market opens on Thursday, May 29, 2025. A copy of the earnings release and full detailed presentation will be available on the Hamilton Lane Shareholders website at https://shareholders.hamiltonlane.com/. Hamilton Lane will host a conference call via webcast at 11:00 a.m. ET on May 29 to discuss the results for the fourth fiscal quarter and full fiscal year. For access to the live event via the webcast, visit Hamilton Lane's Shareholder's website by clicking here (https://sharehold
RED BANK, N.J., April 17, 2025 /PRNewswire/ -- PAX Health, a leading behavioral healthcare company backed by HCAP Partners and funds managed by Hamilton Lane (NASDAQ:HLNE), today announced its acquisition of Richardson Psychiatric Associates, a comprehensive outpatient psychiatric practice serving adults, adolescents, children, and families. This strategic acquisition enhances PAX Health's portfolio of mental health services and expands its geographic footprint in Western Pennsylvania, strengthening the company's ability to deliver high-quality psychiatric care across diverse
CONSHOHOCKEN, Pa., Feb. 4, 2025 /PRNewswire/ -- Leading private markets asset management firm Hamilton Lane Incorporated (NASDAQ:HLNE) today reported its results for the third fiscal quarter ended December 31, 2024. THIRD QUARTER FISCAL 2025 HIGHLIGHTS Assets under management – Total assets under management of $134.7 billion grew $14.8 billion year-over-year. Fee-earning assets under management increased $7.9 billion to $71.0 billion over the same period.Revenue – Management and advisory fees of $126.3 million for the quarter represent growth of 11% versus the prior year period.Carried Interest – Unrealized carried interest balance of approximately $1.3 billion, up 15% versus the prior year
CONSHOHOCKEN, Pa., Jan. 14, 2025 /PRNewswire/ -- Hamilton Lane Incorporated (NASDAQ:HLNE) is scheduled to release financial results for the third fiscal quarter before the market opens on Tuesday, February 4, 2025. A copy of the earnings release and full detailed presentation will be available on the Hamilton Lane Shareholders website at https://shareholders.hamiltonlane.com/. Hamilton Lane will host a conference call via webcast at 11:00 a.m. ET on February 4 to discuss the results for the third fiscal quarter. For access to the live event via the webcast, visit Hamilton Lane's Shareholder's website clicking here (https://shareholders.hamiltonlane.com/) at least 15 minutes prior to the sta
Together with Republic, this initiative seeks to revolutionize access to private markets funds, opening a $13 trillion* global market to retail investors CONSHOHOCKEN, Pa. and NEW YORK, Jan. 14, 2025 /PRNewswire/ -- Hamilton Lane (NASDAQ:HLNE), one of the largest private markets investment firms globally, together with Republic, a leading global investment platform for private market assets, today announced a new partnership that aims to bring institutional-quality private market investments to individual retail investors in the U.S. Through the partnership, the firms intend to launch digital blockchain-based solutions for retail investors, featuring low investment minimums and the pot
CONSHOHOCKEN, Penn., Nov. 6, 2024 /PRNewswire/ -- Leading private markets asset management firm Hamilton Lane Incorporated (NASDAQ:HLNE) today reported its results for the second fiscal quarter ended September 30, 2024. SECOND QUARTER FISCAL 2025 HIGHLIGHTS Assets under management – Total assets under management of $131.4 billion grew $12.2 billion year-over-year. Fee-earning assets under management increased $8.3 billion to $69.7 billion over the same period.Revenue – Management and advisory fees of $119.8 million for the quarter represent growth of 10% versus the prior year period.Carried Interest – Unrealized carried interest balance of approximately $1.3 billion, up 9% versus the prior
CONSHOHOCKEN, Pa., Oct. 16, 2024 /PRNewswire/ -- Hamilton Lane Incorporated (NASDAQ:HLNE) is scheduled to release financial results for the second fiscal quarter before the market opens on Wednesday, November 6, 2024. A copy of the earnings release and full detailed presentation will be available on the Hamilton Lane Shareholders website at https://shareholders.hamiltonlane.com/. Hamilton Lane will host a conference call via webcast at 11:00 a.m. ET on November 6 to discuss the results for the second fiscal quarter. For access to the live event via the webcast, visit Hamilton Lane's Shareholders website by clicking here (https://shareholders.hamiltonlane.com/) at least 15 minutes prior to t
CONSHOHOCKEN, Pa., Aug. 6, 2024 /PRNewswire/ -- Leading private markets asset management firm Hamilton Lane Incorporated (NASDAQ:HLNE) today reported its results for the first fiscal quarter ended June 30, 2024. FIRST QUARTER FISCAL 2025 HIGHLIGHTS Assets under management – Total assets under management of $129.7 billion grew 11% year-over-year. Fee-earning assets under management increased 13% to $67.7 billion over the same period. Revenue – Management and advisory fees of $140.0 million for the quarter represent growth of 33% versus the prior year period. Carried Interest – Unrealized carried interest balance of approximately $1.2 billion was up 12% versus the prior year period. Earnin
CONSHOHOCKEN, Pa., July 16, 2024 /PRNewswire/ -- Hamilton Lane Incorporated (NASDAQ:HLNE) is scheduled to release financial results for the first fiscal quarter before the market opens on Tuesday, August 6, 2024. A copy of the earnings release and full detailed presentation will be available on the Hamilton Lane Shareholders website at https://shareholders.hamiltonlane.com/ Hamilton Lane will host a conference call via webcast at 11:00 a.m. ET on August 6 to discuss the results for the first fiscal quarter. For access to the live event via the webcast, visit Hamilton Lane's Shareholder's website by clicking here (https://shareholders.hamiltonlane.com/) at least 15 minutes prior to the start
CONSHOHOCKEN, Pa., May 23, 2024 /PRNewswire/ -- Leading private markets asset management firm Hamilton Lane Incorporated (NASDAQ:HLNE) today reported its results for the fourth fiscal quarter and full fiscal year ended March 31, 2024. FISCAL YEAR 2024 HIGHLIGHTS Assets under management – Total assets under management of $124 billion grew 11% year-over-year. Fee-earning assets under management increased 15% to $66 billion over the same period.Revenue – Management and advisory fees increased 22% to $451.9 million for fiscal 2024.Carried Interest – Unrealized carried interest balance of $1.2 billion was up 19% year-over-year.Earnings per share – GAAP EPS of $3.69 on $140.9 million of GAAP net
SCHEDULE 13D/A - Hamilton Lane INC (0001433642) (Subject)
SCHEDULE 13D/A - Hamilton Lane INC (0001433642) (Subject)
8-K - Hamilton Lane INC (0001433642) (Filer)
424B5 - Hamilton Lane INC (0001433642) (Filer)
424B5 - Hamilton Lane INC (0001433642) (Filer)
10-Q - Hamilton Lane INC (0001433642) (Filer)
8-K - Hamilton Lane INC (0001433642) (Filer)
SCHEDULE 13G/A - Hamilton Lane INC (0001433642) (Subject)
S-3ASR - Hamilton Lane INC (0001433642) (Filer)
10-Q - Hamilton Lane INC (0001433642) (Filer)
4 - Hamilton Lane INC (0001433642) (Issuer)
Oppenheimer upgraded Hamilton Lane from Perform to Outperform and set a new price target of $186.00
Goldman downgraded Hamilton Lane from Neutral to Sell and set a new price target of $139.00
Wells Fargo initiated coverage of Hamilton Lane with a rating of Equal Weight and set a new price target of $156.00
JP Morgan downgraded Hamilton Lane from Overweight to Neutral and set a new price target of $115.00
Oppenheimer downgraded Hamilton Lane from Outperform to Perform
Oppenheimer upgraded Hamilton Lane from Perform to Outperform and set a new price target of $87.00
JP Morgan upgraded Hamilton Lane from Neutral to Overweight and set a new price target of $85.00
UBS downgraded Hamilton Lane from Buy to Neutral and set a new price target of $75.00 from $72.00 previously
Morgan Stanley reiterated coverage of Hamilton Lane with a rating of Equal-Weight and set a new price target of $111.00 from $120.00 previously
Wells Fargo initiated coverage of Hamilton Lane with a rating of Equal-Weight and set a new price target of $109.00
SC 13G/A - Hamilton Lane INC (0001433642) (Subject)
SC 13G/A - Hamilton Lane INC (0001433642) (Subject)
SC 13G/A - Hamilton Lane INC (0001433642) (Subject)
SC 13D/A - Hamilton Lane INC (0001433642) (Subject)
SC 13D/A - Hamilton Lane INC (0001433642) (Subject)
SC 13G/A - Hamilton Lane INC (0001433642) (Subject)
SC 13G/A - Hamilton Lane INC (0001433642) (Subject)
SC 13G/A - Hamilton Lane INC (0001433642) (Subject)
SC 13G/A - Hamilton Lane INC (0001433642) (Subject)
SC 13D/A - Hamilton Lane INC (0001433642) (Subject)
Grenova, Inc., a Virginia-based innovator in sustainable laboratory technologies, today announced two significant milestones for the company: the appointment of Ted Hull to Grenova's board, and the successful completion of a new round of growth equity capital. These developments support Grenova's strategic vision to drive innovation, expand automation capabilities, and deliver transformative solutions to laboratories worldwide. Ted Hull brings over 30 years of experience in the life sciences industry, including as a clinical lab CEO for the last 20+ years. In his role at Grenova, Mr. Hull is set to provide strategic leadership and to play a pivotal role in shaping the company's future. "I
Industry leader with 35+ years of experience in manufacturing operations and global supply chain excellence Cosette Pharmaceuticals, Inc., a leading specialty pharmaceuticals company, today announced the appointment of Vincent (Vin) Colicchio as Senior Vice President of Operations, effective February 3, 2025. In this role, Vin will lead Cosette's manufacturing, global supply chain, and operational strategy, ensuring efficiency, and supply continuity as the company continues its strong trajectory of growth and transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250210366017/en/Senior Vice President, Operations (Photo
Experienced commercial leader joins Cosette to drive the next phase of growth and transformation Cosette Pharmaceuticals, Inc., a leading specialty pharmaceuticals company, today announced the appointment of Brad Leonard as Vice President, Generics Commercial Operations. In this role, Brad will spearhead Cosette's generics business, including Generics Sales, Marketing/Pricing, Customer Service, and Demand Planning, as the company continues its expansion in these markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250203104224/en/Brad Leonard, Vice President, Generics Commercial Operations (Photo: Business Wire) "Cosette is
The firm broadens its co-investment capabilities with the additions of five senior team membersGlobal appointments highlight continued growth within the asset class and historic success of the firm's Direct Equity platform, which stands at $15.3 billion in AUM* CONSHOHOCKEN, Pa., Nov. 12, 2024 /PRNewswire/ -- Leading private markets investment management firm Hamilton Lane (NASDAQ:HLNE) today announced the expansion of its Direct Equity Investment Team, with the appointment of five new senior team members based in North America and Europe to support the continued growth of the asset class.
NEW YORK, Sept. 6, 2024 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 23, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P SmallCap 600 are more representative of the small-cap market space. The companies being removed from
Appointments underscore the firm's commitment to meet the growing interest of insurers in bolstering portfolios through broadened exposure to private markets CONSHOHOCKEN, Pa., July 29, 2024 /PRNewswire/ -- Leading private markets investment management firm Hamilton Lane (NASDAQ:HLNE) today announced the creation of a dedicated Insurance Solutions team, formalizing its long-standing efforts to serve insurers and enhance its focus on investments and client support with the appointment of two senior team members. Eric Solfisburg has joined Hamilton Lane as an Insurance Strategist within the firm's Direct Credit team, and Kyle Ross has joined the Insurance Client Solutions team. John Brecker
Elevations to MD and Principal come amid continued firm growth and recent awardsFirm appoints Kate Reilly to new role of COO of Client Solutions OperationsCONSHOHOCKEN, Pa., April 3, 2024 /PRNewswire/ -- Leading private markets investment management firm Hamilton Lane (NASDAQ:HLNE) today announced a number of senior promotions, including Investment, Client Solutions, Portfolio Management, Technology, Shareholder Relations, Legal, Finance and Operations Teams. The firm recognized the promotions of the following 16 individuals to Managing Director – the largest group of MDs to date. Antony Anastasiadis, Secondary InvestmentsBryan Jenkins, Portfolio Management GroupDenise Dunbar, ControllerDr
Jeffrey Armbrister, Lindy Benton-Moreno, and Connie Collingsworth join the Board of Trustees at the largest national, independent donor-advised fund public charity National Philanthropic Trust (NPT), the largest national, independent public charity that manages donor-advised funds, and one of the leading grantmaking institutions in the U.S., is pleased to announce the appointment of Jeffrey Armbrister, Lindy Benton-Moreno, and Connie Collingsworth to its Board of Trustees. "As NPT continues to grow, innovate, and advance philanthropy around the world, we welcome these three accomplished professionals to our Board of Trustees," said Eileen Heisman, CEO of National Philanthropic Trust. "N
Scott Thomas joins as Head of Private Wealth for Australia Appointment comes as the firm's Global Private Assets Fund marks its four-year anniversary SYDNEY, 19 June 2023 /PRNewswire/ -- Leading private markets investment management firm Hamilton Lane (NASDAQ:HLNE) today announced the appointment of Scott Thomas as Head of Private Wealth, Australia. In this newly created role, Mr. Thomas will serve the firm's high-net-worth investors (HNWIs) in the region, as investor interest in private markets continues to grow. His role will also involve expanding the firm's distribution efforts and will be based in Hamilton Lane's Sydney office, which has expanded to nine professionals across Portfolio
Novata is the premier ESG data management platform for private markets Ms. Sutphen will provide a valuable viewpoint on ESG from a political and regulatory background Novata, a public benefit corporation and technology platform that provides private markets stakeholders with intuitive and effective Environmental, Social and Governance (ESG) data management solutions, today announced the appointment of Mona Sutphen, Partner and Head of Investment Strategies at The Vistria Group (Vistria), to Novata's Board of Directors, effective immediately. Ms. Sutphen has spent over two decades at the intersection of the public and private sectors. Prior to joining Vistria, she was a Partner at global